Neuroscience
Carnitine Palmitoyltransferase I
100%
Metabolic Pathway
100%
Parkinson's Disease
66%
Central Nervous System
50%
Nervous System Disorder
50%
Proton Pump Inhibitor
50%
Brain Protein
50%
Rotenone
41%
Neurodegeneration
33%
Multiple Sclerosis
16%
Epigenetics
16%
Amyotrophic Lateral Sclerosis
16%
Carnitine O-Palmitoyltransferase
8%
Midbrain
8%
Behavior (Neuroscience)
8%
Oxidative Stress
8%
Myelin Basic Protein
7%
Brain Antigen
7%
Pharmacology, Toxicology and Pharmaceutical Science
Carnitine Palmitoyltransferase I
100%
Mouse Model
100%
Parkinson's Disease
50%
Disease Exacerbation
50%
Brain Protein
50%
Amyotrophic Lateral Sclerosis
50%
Knockout Mouse
30%
Rotenone
30%
Dysbiosis
20%
Mutant Mouse Strain
16%
Allergic Encephalomyelitis
16%
Myelin
12%
Brain Antigen
12%
Myelin Basic Protein
12%
Long Chain Fatty Acid
10%
Carnitine Palmitoyltransferase
10%
Mouse Mutant
10%
Motor Neuron Disease
8%
Intestine Flora
8%
mSOD1 Mouse
8%
Disease
8%
Inflammation
8%
Symptom
8%
Keyphrases
Eosinophilic Esophagitis
50%
SOD1G93A Mice
50%
Experimental Autoimmune Encephalomyelitis
50%
Gender Differences
50%
Brain Proteins
50%
PARK2
37%
CNS Disorders
25%
Production Cell
12%
Myelin Basic Protein
12%
Non-motor Behavior
12%
Rotenone Model
12%
Central Metabolic Pathways
12%
Myelin Sheath
12%
Brain Antigens
12%
Epitope Spreading
10%
Altered Peptide Ligands
10%
Loss of Tolerance
10%
Self-protein
10%
Histological Response
8%
Proton Pump Inhibitors
8%
Dysregulated Metabolism
8%
Working Diagnosis
8%
Pharmacological Methods
8%
Histopathological Findings
8%
Corticosterone
8%
Adult Patients
8%
Macroscopic Findings
8%
Denmark
8%
Population-based
8%
Clinically Significant
8%
Food Bolus Obstruction
8%
Pathology Report
8%
Clinical Phenotype
8%
Treatment Response
8%
Medical Records
8%
Registry-based
8%
Patient Registry
8%
Adult Men
8%
Adult Women
8%
